[22, 23], tailored peptide-based inhibitors may provide a means to selectively target individual granzymes in lysis assays. As a starting point for determining the feasibility of such an approach, the extended substrate specificities of all human granzymes were compared by using combinatorial libraries of protease substrates. The optimal P4-P3-P2-P1 (nomenclature for amino acid positions in substrates is Pn, Pn-1, ..., P2, P1 with amide bond hydrolysis occurring following P1) substrate specificities of the five human granzymes were determined to be IGNR for granzyme A, IEPD for granzyme B, PTSY for granzyme H, YRFK for granzyme K, and . Although the optimal substrate specificity of tained by using cytotoxic lymphocytes from granzymegranzyme A has previously been determined to be deficient mice, or reconstituted systems of purified VANR, the single substrate Ac-IGNR-ACC was found to granzymes and perforin, these studies revealed granbe approximately twice as sensitive as Ac-VANR-ACC zyme A to be a minor effector and granzyme B to be a
(data not shown). Previous studies have demonstrated major effector of target cell lysis by NK cells. that granzyme H exhibits a preference for aromatic residues at P1 [26] and that granzyme K exhibits a preferResults
ence for lysine and arginine at P1 [27] . The library profiles indicate that granzyme H, in fact, exhibits a strong Serine and Cysteine Protease Inhibitors, but Not preference for tyrosine over phenylalanine and tryptoCaspase Inhibitors, Block NK Cell-Mediated phan at this position, while granzyme K exhibits a Lysis of Target Cells strong preference for lysine over arginine. The P4-P2 To confirm prior findings related to which protease substrate specificities of these two granzymes have not classes are required for cytotoxic lymphocyte-medibeen previously characterized. The narrow specificity ated cell lysis, cytotoxicity assays were carried out in of the five granzymes at P1 is particularly remarkable. the presence of the caspase inhibitors Z-VAD-FMK and Since serine proteases derive much of the energy re-Z-DEVD-FMK, the serine protease inhibitor DCI (3,4-quired for catalysis from binding P1, this property dichloroisocoumarin), and the cysteine protease inhibishould aid in achieving selective chemical inhibition of tor E-64d (Figure 1 ). The NK cell line NK-92 and the NKa particular family member [28] . In instances in which sensitive target cell line K562 were used as a model some crossreactivity may be expected at P1, such as effector and target cell pair, respectively. A combination with granzymes A and K, distinct specificities at P4-P2 of Z-VAD-FMK and Z-DEVD-FMK only had a minor efshould further contribute to selectivity. fect on cell lysis, in agreement with prior studies [17] . In contrast, DCI was found to be a potent inhibitor of lysis, again in agreement with prior studies [18] . The Substrate Specificity-Based Phosphonate Inhibitors as Affinity Labels of Granzymes A and B cysteine protease inhibitor E-64d was also found to be a potent inhibitor of lysis, possibly as a consequence Recombinant granzymes A, B, H, and M were profiled at positions P4-P1 by using a completely diversified PS-SCL of ACC substrates. Granzyme K was profiled at P4-P2 by using a PS-SCL of ACC substrates that is fixed as lysine at P1, and was profiled at P1 by using the P1-Arg and P1-Lys wells of the completely diversified PS-SCL. The y axis represents relative activity, and the x axis represents the fixed P4, P3, P2, or P1 amino acid (with norleucine represented by n). Activities for each enzyme are relative to the highest activity at each of the four substrate positions.
cate that bio-x-IGN(AmPhg) P -(OPh) 2 and bio-x-IEPD Pwere preinactivated by denaturation with 2% SDS. Immunoprecipitation of human granzyme A or B from ly-(OPh) 2 function as irreversible inhibitors of their target enzymes ( Figures 3A and 3B) . Activity assays of recomsates treated with inhibitors followed by avidin blotting of immunoprecipitates demonstrates that the protein binant enzymes also indicate that both compounds are selective for their target enzymes in the context of the labeled by bio-x-IGN(AmPhg) P -(OPh) 2 is granzyme A and the protein labeled by bio-x-IEPD P -(OPh) 2 is grangranzyme family (Table 1) . zyme B (Figures 4C and 4D by RNA interference. A common drawback of using small molecules as functional probes is crossreactivity with unintended targets, particularly when the intended served with bio-x-IEPD P -(OPh) 2 in the cell lysis assays, the decreased granzyme B levels in NKL cells correlate target is highly homologous to a set of other proteins. An elegant and generalizable solution to this problem, with the lower lytic potential exhibited by this cell line ( Figure 6C) . which combines synthetic chemistry and genetics, has been applied to the study of protein kinases [32] . A similarly generalizable approach has yet to be develDiscussion oped for proteases. The inhibitors described herein were developed with Genetic studies of granzymes A and B have greatly contributed to the understanding of these two protethe goal of establishing chemical probes to further current understanding of granzymes A and B. As a means ases as effectors of cell-based immunity. The increased susceptibility to viral infection exhibited by mice lackto account for potential inhibitor crossreactivity, these compounds were designed as tagged affinity labels. ing either one or both of these granzymes is especially 
